Tolerability of Higher Than Current Infusion Rate and Volume of the 20% Subcutaneous Immunoglobulin IgPro20 in Primary Immunodeficiency: An Open-Label Multicenter Study (HiLo)
Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.346
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Publisher
Elsevier BV